{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:58:12Z","timestamp":1770379092635,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01794-z","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:18:51Z","timestamp":1770279531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the therapeutic potential of the gut microbiota metabolite 3\u2011indolepropionic acid in parkinson\u2019s disease: a network pharmacology, molecular docking and cell viability study"],"prefix":"10.1007","volume":"41","author":[{"given":"Qiuyue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1794_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vph.2015.05.008","volume":"74","author":"P Abeyrathna","year":"2015","unstructured":"Abeyrathna P, Su Y (2015) The critical role of Akt in cardiovascular function. Vascul Pharmacol 74:38\u201348. https:\/\/doi.org\/10.1016\/j.vph.2015.05.008","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"1794_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::aid-mds1006>3.0.co;2-y","volume":"14","author":"C Anderson","year":"1999","unstructured":"Anderson C, Checkoway H, Franklin GM et al (1999) Dietary factors in parkinson\u2019s disease: the role of food groups and specific foods. Mov Disord 14(1):21\u201327.https:\/\/doi.org\/10.1002\/1531-8257(199901)14:1%3C21::aid-mds1006%3E3.0.co;2-y","journal-title":"Mov Disord"},{"key":"1794_CR3","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C et al (2022) Neuroinflammation and parkinson\u2019s Disease-From neurodegeneration to therapeutic opportunities. Cells 11:2908. https:\/\/doi.org\/10.3390\/cells11182908","journal-title":"Cells"},{"key":"1794_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2019.00239","volume":"10","author":"J Campos-Acu\u00f1a","year":"2019","unstructured":"Campos-Acu\u00f1a J, Elgueta D, Pacheco R (2019) T-Cell-Driven inflammation as a mediator of the Gut-Brain axis involved in parkinson\u2019s disease. Front Immunol 10:239. https:\/\/doi.org\/10.3389\/fimmu.2019.00239","journal-title":"Front Immunol"},{"key":"1794_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mds.27862","volume":"35","author":"KR Chaudhuri","year":"2020","unstructured":"Chaudhuri KR, Schrag A, Weintraub D et al (2020) The movement disorder society nonmotor rating scale: initial validation study. Mov Disord 35:116\u2013133. https:\/\/doi.org\/10.1002\/mds.27862","journal-title":"Mov Disord"},{"issue":"1","key":"1794_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41467-024-44772-8","volume":"15","author":"T Chen","year":"2024","unstructured":"Chen T, Xie S, Cheng J et al (2024) AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to Glycolysis for tumorigenesis. Nat Commun 15(1):686. https:\/\/doi.org\/10.1038\/s41467-024-44772-8","journal-title":"Nat Commun"},{"key":"1794_CR6","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.redox.2022.102430","volume":"56","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Wang J, Li M et al (2022) CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in parkinson\u2019s disease. Redox Biol 56:102430. https:\/\/doi.org\/10.1016\/j.redox.2022.102430","journal-title":"Redox Biol"},{"key":"1794_CR8","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","volume":"84","author":"JC Claudino Dos Santos","year":"2023","unstructured":"Claudino Dos Santos JC, Lima MPP, Brito GAC et al (2023) Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis. Ageing Res Rev 84:101812. https:\/\/doi.org\/10.1016\/j.arr.2022.101812","journal-title":"Ageing Res Rev"},{"issue":"11","key":"1794_CR9","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis F, Pellegrini N, Vannini L et al (2016) High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65(11):1812\u20131821. https:\/\/doi.org\/10.1136\/gutjnl-2015-309957","journal-title":"Gut"},{"key":"1794_CR10","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators (2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet 403:2100\u20132132. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2","journal-title":"Lancet"},{"key":"1794_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/13813455.2021.2024577","volume":"130","author":"C Gundu","year":"2022","unstructured":"Gundu C, Arruri VK, Sherkhane B et al (2022) Indole-3-propionic acid attenuates high glucose induced ER stress response and augments mitochondrial function by modulating PERK-IRE1-ATF4-CHOP signalling in experimental diabetic neuropathy. Arch Physiol Biochem 130:243\u2013256. https:\/\/doi.org\/10.1080\/13813455.2021.2024577","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"1794_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s11427-024-2789-1","volume":"68","author":"Z Han","year":"2025","unstructured":"Han Z, Fu J, Gong A et al (2025) Bacterial indole-3-propionic acid inhibits macrophage IL-1\u03b2 production through targeting methionine metabolism. Sci China Life Sci 68(4):1118\u20131131. https:\/\/doi.org\/10.1007\/s11427-024-2789-1","journal-title":"Sci China Life Sci"},{"key":"1794_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00702-024-02863-2","volume":"131","author":"N Hattori","year":"2024","unstructured":"Hattori N, Sato S (2024) Mitochondrial dysfunction in parkinson\u2019s disease. J Neural Transm (Vienna) 131:1415\u20131428. https:\/\/doi.org\/10.1007\/s00702-024-02863-2","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"1794_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-024-01755-7","volume":"12","author":"J Jiang","year":"2024","unstructured":"Jiang J, Wang D, Jiang Y et al (2024) The gut metabolite indole-3-propionic acid activates ERK1 to restore social function and hippocampal inhibitory synaptic transmission in a 16p11.2 microdeletion mouse model. Microbiome 12(1):66. https:\/\/doi.org\/10.1186\/s40168-024-01755-7","journal-title":"Microbiome"},{"key":"1794_CR16","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.3390\/nu14214678","volume":"14","author":"T Li","year":"2022","unstructured":"Li T, Chu C, Yu L et al (2022) Neuroprotective effects of bifidobacterium Breve CCFM1067 in MPTP-Induced mouse models of parkinson\u2019s disease. Nutrients 14:4678. https:\/\/doi.org\/10.3390\/nu14214678","journal-title":"Nutrients"},{"issue":"48","key":"1794_CR15","doi-asserted-by":"publisher","first-page":"eadw8410","DOI":"10.1126\/sciadv.adw8410","volume":"11","author":"L Li","year":"2025","unstructured":"Li L, Jia M, Yang C et al (2025) Gut microbial-derived indole-3-propionate improves cognitive function in alzheimer\u2019s disease. Sci Adv 11(48):eadw8410. https:\/\/doi.org\/10.1126\/sciadv.adw8410","journal-title":"Sci Adv"},{"key":"1794_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW et al (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"1794_CR18","doi-asserted-by":"publisher","first-page":"648636","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long HZ, Cheng Y, Zhou ZW et al (2021) PI3K\/AKT signal pathway: A target of natural products in the prevention and treatment of alzheimer\u2019s disease and parkinson\u2019s disease. Front Pharmacol 12:648636. https:\/\/doi.org\/10.3389\/fphar.2021.648636","journal-title":"Front Pharmacol"},{"key":"1794_CR19","doi-asserted-by":"publisher","first-page":"109571","DOI":"10.1016\/j.intimp.2022.109571","volume":"114","author":"YT Mohamed","year":"2023","unstructured":"Mohamed YT, Salama A, Rabie MA et al (2023) Neuroprotective effect of Secukinumab against rotenone induced parkinson\u2019s disease in rat model: involvement of IL-17, HMGB-1\/TLR4 axis and BDNF\/TrKB cascade. Int Immunopharmacol 114:109571. https:\/\/doi.org\/10.1016\/j.intimp.2022.109571","journal-title":"Int Immunopharmacol"},{"key":"1794_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM et al (2024) The pathogenesis of parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"1794_CR21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/jnr.25239","volume":"101","author":"AA Mugayar","year":"2023","unstructured":"Mugayar AA, da Silva Guimar\u00e3es G, de Oliveira PHT et al (2023) Apoptosis in the neuroprotective effect of \u03b17 nicotinic receptor in neurodegenerative models. J Neurosci Res 101:1795\u20131802. https:\/\/doi.org\/10.1002\/jnr.25239","journal-title":"J Neurosci Res"},{"key":"1794_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12031-024-02297-1","volume":"74","author":"CT Raghavan","year":"2024","unstructured":"Raghavan CT (2024) )Advanced glycation end products in neurodegenerative diseases. J Mol Neurosci 74:114. https:\/\/doi.org\/10.1007\/s12031-024-02297-1","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1794_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr MW, Narasimhulu CA, Rudeski-Rohr TA et al (2020) Negative effects of a High-Fat diet on intestinal permeability: A review. Adv Nutr 11(1):77\u201391. https:\/\/doi.org\/10.1093\/advances\/nmz061","journal-title":"Adv Nutr"},{"key":"1794_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2023","unstructured":"Salim S, Ahmad F, Banu A et al (2023) Gut Microbiome and parkinson\u2019s disease: perspective on pathogenesis and treatment. J Adv Res 50:83\u2013105. https:\/\/doi.org\/10.1016\/j.jare.2022.10.013","journal-title":"J Adv Res"},{"key":"1794_CR24","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1007\/s12035-016-0129-3","volume":"54","author":"AK Singh","year":"2017","unstructured":"Singh AK, Kashyap MP, Tripathi VK et al (2017) )Neuroprotection through Rapamycin-Induced activation of autophagy and PI3K\/Akt1\/mTOR\/CREB signaling against Amyloid-\u03b2-Induced oxidative Stress, Synaptic\/Neurotransmission Dysfunction, and neurodegeneration in adult rats. Mol Neurobiol 54:5815\u20135828. https:\/\/doi.org\/10.1007\/s12035-016-0129-3","journal-title":"Mol Neurobiol"},{"key":"1794_CR26","doi-asserted-by":"publisher","first-page":"105840","DOI":"10.1016\/j.phrs.2021.105840","volume":"172","author":"K Soca\u0142a","year":"2021","unstructured":"Soca\u0142a K, Doboszewska U, Szopa A et al (2021) The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840. https:\/\/doi.org\/10.1016\/j.phrs.2021.105840","journal-title":"Pharmacol Res"},{"key":"1794_CR27","doi-asserted-by":"publisher","first-page":"e1002056","DOI":"10.1371\/journal.pmed.1002056","volume":"13","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE et al (2016) GATHER working Group. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med 13:e1002056. https:\/\/doi.org\/10.1371\/journal.pmed.1002056","journal-title":"PLoS Med"},{"key":"1794_CR28","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"5388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021. BMJ 5388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"1794_CR29","doi-asserted-by":"publisher","first-page":"e13522","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu HY, Yuan BS, Hou XO et al (2021) \u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of parkinson\u2019s disease. Aging Cell 20:e13522. https:\/\/doi.org\/10.1111\/acel.13522","journal-title":"Aging Cell"},{"key":"1794_CR30","doi-asserted-by":"publisher","first-page":"117628","DOI":"10.1016\/j.jep.2023.117628","volume":"25","author":"L Yu","year":"2024","unstructured":"Yu L, Hu X, Xu R et al (2024) Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in parkinson\u2019s disease rats. J Ethnopharmacol 25:322:117628. https:\/\/doi.org\/10.1016\/j.jep.2023.117628","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1794_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"15","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J (2023) Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener 15(1):59. https:\/\/doi.org\/10.1186\/s40035-023-00392-8","journal-title":"Transl Neurodegener"},{"key":"1794_CR32","doi-asserted-by":"publisher","first-page":"101347","DOI":"10.1016\/j.arr.2021.101347","volume":"69","author":"SY Zheng","year":"2021","unstructured":"Zheng SY, Li HX, Xu RC et al (2021) Potential roles of gut microbiota and microbial metabolites in parkinson\u2019s disease. Ageing Res Rev 69:101347. https:\/\/doi.org\/10.1016\/j.arr.2021.101347","journal-title":"Ageing Res Rev"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01794-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01794-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01794-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:18:52Z","timestamp":1770279532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01794-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01794-z","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}